Heyman Richard A.
Insider CIK 1584759 · YMTX Director · RCPT Director · ONVO Director · MTCR Director · GRTS Director · ELVN Director · PMVP Director · ORIC Director · RYZB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2026-10-01 | 2026-10-02 | 3,500 | — | $0 | 26,700 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2026-10-01 | 2026-10-02 | 3,200 | $12.91 | $41.3K | 203,472 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2026-10-01 | 2026-10-02 | 3,500 | $12.91 | $45.2K | 38,300 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2026-10-01 | 2026-10-02 | 3,500 | $1.60 | $5.6K | 41,800 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2026-07-24 | 2026-07-28 | 3,500 | — | $0 | 30,200 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2026-07-24 | 2026-07-28 | 6,100 | $12.02 | $73.3K | 206,672 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2026-07-24 | 2026-07-28 | 7,000 | $12.02 | $84.1K | 38,300 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2026-07-24 | 2026-07-28 | 3,500 | $1.60 | $5.6K | 45,300 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2026-07-24 | 2026-07-28 | 3,500 | — | $0 | 30,200 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2026-07-24 | 2026-07-28 | 6,100 | $12.02 | $73.3K | 206,672 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2026-07-24 | 2026-07-28 | 7,000 | $12.02 | $84.1K | 38,300 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2026-07-24 | 2026-07-28 | 3,500 | $1.60 | $5.6K | 45,300 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2026-07-06 | 2026-07-08 | 300 | $12.00 | $3.6K | 212,772 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-02-17 | 2026-02-19 | 1,230 | $26.18 | $32.2K | 22,647 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2026-02-12 | 2026-02-17 | 19,234 | — | $0 | 19,234 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-01-20 | 2026-01-22 | 718 | $26.96 | $19.4K | 23,877 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-01-20 | 2026-01-22 | 512 | $26.46 | $13.5K | 24,595 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2026-01-16 | 2026-01-20 | 3,500 | $12.00 | $42.0K | 41,800 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2026-01-16 | 2026-01-20 | 3,200 | $12.00 | $38.4K | 213,072 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-01-09 | 2026-01-12 | 4,285 | $25.00 | $107.1K | 25,107 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-01-08 | 2026-01-12 | 1,620 | $25.00 | $40.5K | 25,545 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-01-08 | 2026-01-12 | 8,015 | $25.04 | $200.7K | 29,392 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2025-10-03 | 2025-10-03 | 18,125 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2025-10-03 | 2025-10-03 | 13,228 | — | $0 | 33,700 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise deriv | 2025-10-03 | 2025-10-03 | 1,447 | — | $0 | 52,253 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2025-10-03 | 2025-10-03 | 1,447 | $3.75 | $5.4K | 45,300 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | M Exercise | 2025-10-03 | 2025-10-03 | 31,353 | $1.60 | $50.2K | 43,853 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 33,500 | — | $0 | 33,500 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2025-02-06 | 2025-02-10 | 23,014 | — | $0 | 23,014 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2025-01-02 | 2025-01-06 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-22 | 817 | $30.00 | $24.5K | 123,673 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-22 | 753 | $30.00 | $22.6K | 27,165 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-15 | 2024-10-17 | 1,270 | $27.67 | $35.1K | 124,490 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-04 | 2024-10-08 | 2,825 | $27.51 | $77.7K | 125,760 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 518 | $27.54 | $14.3K | 128,585 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-09-16 | 2024-09-18 | 1,270 | $22.41 | $28.5K | 129,103 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-08-15 | 2024-08-19 | 620 | $23.70 | $14.7K | 130,373 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-08-15 | 2024-08-19 | 650 | $22.82 | $14.8K | 130,993 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-31 | 2024-08-02 | 1,702 | $27.51 | $46.8K | 131,643 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-31 | 2024-08-02 | 649 | $27.50 | $17.8K | 27,918 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-15 | 2024-07-17 | 1,270 | $24.80 | $31.5K | 133,345 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-06-17 | 2024-06-20 | 1,270 | $21.48 | $27.3K | 134,615 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 25,600 | — | $0 | 25,600 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 67,500 | — | $0 | 67,500 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-05-16 | 2024-05-20 | 1,270 | $23.74 | $30.1K | 135,885 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-15 | 2024-04-15 | 80 | $20.68 | $1.7K | 137,155 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-15 | 2024-04-15 | 1,190 | $19.94 | $23.7K | 137,235 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-11 | 2024-04-15 | 5,045 | $25.03 | $126.3K | 138 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-11 | 2024-04-15 | 649 | $25.00 | $16.2K | 28,567 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-03-19 | 2024-03-21 | 1,270 | $14.50 | $18.4K | 143,470 | SEC↗ |
| RYZB RayzeBio, Inc. | D To issuer | 2024-02-26 | 2024-02-27 | 367,446 | $62.50 | $22.97M | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-02-15 | 2024-02-20 | 1,270 | $17.42 | $22.1K | 144,740 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 21,043 | — | $0 | 21,043 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-20 | 29,205 | — | $0 | 29,205 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-01-30 | 2024-02-01 | 1,270 | $16.41 | $20.8K | 146,010 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-22 | 2023-12-26 | 35 | $13.00 | $455 | 29,216 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-22 | 2023-12-26 | 168 | $13.00 | $2.2K | 147,280 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-21 | 2023-12-26 | 6 | $13.00 | $78 | 29,251 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-21 | 2023-12-26 | 7 | $13.00 | $91 | 147,448 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-20 | 2023-12-21 | 2,110 | $13.02 | $27.5K | 147,455 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-20 | 2023-12-21 | 1,915 | $13.02 | $24.9K | 29,257 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-19 | 2023-12-21 | 255 | $13.00 | $3.3K | 149,565 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2023-06-14 | 2023-06-15 | 20,500 | — | $0 | 20,500 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 21,500 | — | $0 | 21,500 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2023-02-23 | 2023-04-06 | 34,458 | — | $0 | 34,458 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2023-02-23 | 2023-02-27 | 20,657 | — | $0 | 20,657 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award | 2023-02-23 | 2023-02-27 | 31,172 | — | $0 | 31,172 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award | 2023-02-23 | 2023-02-27 | 37,407 | — | $0 | 37,407 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award | 2023-02-23 | 2023-02-27 | 149,820 | — | $0 | 149,820 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2022-06-17 | 2022-06-17 | 53,700 | — | $0 | 53,700 | SEC↗ |
| GRTS Gritstone bio, Inc. | A Award deriv | 2022-06-17 | 2022-06-22 | 19,000 | — | $0 | 19,000 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 19,500 | — | $0 | 19,500 | SEC↗ |
| MTCR Metacrine, Inc. | A Award deriv | 2022-05-18 | 2022-09-06 | 16,500 | — | $0 | 16,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-09-15 | 2021-09-16 | 682 | $25.03 | $17.1K | 216,272 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-09-14 | 2021-09-16 | 706 | $25.05 | $17.7K | 216,954 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-09-13 | 2021-09-14 | 601 | $25.01 | $15.0K | 217,660 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-09-10 | 2021-09-14 | 479 | $25.10 | $12.0K | 218,261 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-09-07 | 2021-09-09 | 1,086 | $25.11 | $27.3K | 218,740 | SEC↗ |
| GRTS Gritstone bio, Inc. | A Award deriv | 2021-06-18 | 2021-11-19 | 19,000 | — | $0 | 19,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 16,625 | — | $0 | 16,625 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award deriv | 2021-06-02 | 2021-06-04 | 14,800 | — | $0 | 14,800 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2021-06-02 | 2021-06-09 | 16,333 | — | $0 | 16,333 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise deriv | 2021-06-01 | 2021-06-02 | 1,950 | — | $0 | 15,901 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise deriv | 2021-06-01 | 2021-06-02 | 975 | — | $0 | 7,951 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise deriv | 2021-06-01 | 2021-06-02 | 975 | — | $0 | 7,951 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2021-06-01 | 2021-06-02 | 1,392 | $32.15 | $44.8K | 558 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise | 2021-06-01 | 2021-06-02 | 975 | $975.00 | $950.6K | 975 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2021-06-01 | 2021-06-02 | 764 | $32.15 | $24.6K | 211 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2021-06-01 | 2021-06-02 | 209 | $33.79 | $7.1K | 2 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2021-06-01 | 2021-06-02 | 2 | $34.67 | $69 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise | 2021-06-01 | 2021-06-02 | 1,950 | $2.95 | $5.8K | 1,950 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2021-06-01 | 2021-06-02 | 2 | $34.67 | $69 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2021-06-01 | 2021-06-02 | 743 | $32.16 | $23.9K | 232 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | M Exercise | 2021-06-01 | 2021-06-02 | 975 | $2.95 | $2.9K | 975 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2021-06-01 | 2021-06-02 | 5 | $34.67 | $173 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2021-06-01 | 2021-06-02 | 553 | $33.61 | $18.6K | 5 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2021-06-01 | 2021-06-02 | 230 | $33.75 | $7.8K | 2 | SEC↗ |
| MTCR Metacrine, Inc. | A Award deriv | 2021-05-24 | 2021-05-25 | 16,500 | — | $0 | 16,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-24 | 2021-05-24 | 100 | $25.00 | $2.5K | 219,826 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-21 | 2021-05-24 | 600 | $25.25 | $15.2K | 219,926 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-20 | 2021-05-24 | 700 | $25.08 | $17.6K | 220,526 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-18 | 2021-05-18 | 2,161 | $25.32 | $54.7K | 221,226 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-17 | 2021-05-18 | 498 | $25.07 | $12.5K | 223,387 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-14 | 2021-05-18 | 3,215 | $25.31 | $81.4K | 223,885 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2021-05-12 | 2021-07-23 | 5,781 | — | $0 | 5,781 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-05-11 | 2021-05-13 | 100 | $25.11 | $2.5K | 227,100 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-04-30 | 2021-04-30 | 100 | $25.26 | $2.5K | 227,200 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-04-28 | 2021-04-30 | 100 | $25.08 | $2.5K | 227,300 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | S Sale | 2021-04-01 | 2021-04-05 | 100 | $25.00 | $2.5K | 227,400 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award | 2021-02-01 | 2021-02-03 | 1,959 | — | $0 | 8,117 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award deriv | 2020-12-22 | 2020-12-28 | 5,271 | — | $0 | 5,271 | SEC↗ |
| YMTX YUMANITY THERAPEUTICS, INC | A Award | 2020-12-22 | 2020-12-28 | 6,158 | — | $0 | 6,158 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2020-11-11 | 2020-11-12 | 45,332 | — | $0 | 45,332 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | A Award deriv | 2020-06-18 | 2020-06-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | C Conversion deriv | 2020-04-28 | 2020-04-28 | 62,500 | — | $0 | 0 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | C Conversion | 2020-04-28 | 2020-04-28 | 62,500 | — | $0 | 227,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2020-04-23 | 2020-04-27 | 16,625 | — | $0 | 16,625 | SEC↗ |
| GRTS Gritstone Oncology, Inc. | A Award deriv | 2019-06-19 | 2019-06-20 | 8,570 | — | $0 | 8,570 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 18,800 | $192.52 | $3.62M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer | 2015-08-27 | 2015-08-27 | 7,400 | — | $0 | 0 | SEC↗ |
| ONVO ORGANOVO HOLDINGS, INC. | A Award deriv | 2015-08-20 | 2015-08-24 | 37,000 | — | $0 | 37,000 | SEC↗ |
| RCPT Receptos, Inc. | A Award | 2015-05-28 | 2015-06-01 | 7,400 | — | $0 | 7,400 | SEC↗ |
| ONVO ORGANOVO HOLDINGS, INC. | A Award deriv | 2014-08-20 | 2014-08-26 | 31,500 | — | $0 | 31,500 | SEC↗ |
| RCPT Receptos, Inc. | A Award deriv | 2014-07-28 | 2014-07-29 | 18,800 | — | $0 | 18,800 | SEC↗ |
| ONVO ORGANOVO HOLDINGS, INC. | A Award deriv | 2013-08-21 | 2013-08-23 | 30,500 | — | $0 | 30,500 | SEC↗ |
| ONVO ORGANOVO HOLDINGS, INC. | A Award deriv | 2013-08-21 | 2013-08-23 | 54,000 | — | $0 | 54,000 | SEC↗ |